Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
miglitol lysosomal alpha-glucosidase small molecule NA drugbank , DGIDB Diabetes Mellitus[MeSHID:D003920]
Diet therapy[MeSHID:D004035]
Hyperglycemia[MeSHID:D006943]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]
1.87 approved antagonist,inhibitor
miglitol lysosomal alpha-glucosidase small molecule NA drugbank , DGIDB Diabetes Mellitus[MeSHID:D003920]
Diet therapy[MeSHID:D004035]
Hyperglycemia[MeSHID:D006943]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]
1.87 approved antagonist
miglitol neutral alpha-glucosidase ab small molecule NA drugbank Diabetes Mellitus[MeSHID:D003920]
Diet therapy[MeSHID:D004035]
Hyperglycemia[MeSHID:D006943]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]
NA approved antagonist
miglitol neutral alpha-glucosidase c small molecule NA drugbank Diabetes Mellitus[MeSHID:D003920]
Diet therapy[MeSHID:D004035]
Hyperglycemia[MeSHID:D006943]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]
NA approved antagonist
miglitol intestinal maltase-glucoamylase NA Successful target TTD , DGIDB Diabetes Mellitus[MeSHID:D003920]
Diet therapy[MeSHID:D004035]
Hyperglycemia[MeSHID:D006943]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]
16.97 approved inhibitor
miglitol maltase-glucoamylase, intestinal small molecule NA drugbank , DGIDB Diabetes Mellitus[MeSHID:D003920]
Diet therapy[MeSHID:D004035]
Hyperglycemia[MeSHID:D006943]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]
16.97 approved antagonist,inhibitor
miglitol intestinal maltase-glucoamylase NA Successful target TTD , DGIDB Diabetes Mellitus[MeSHID:D003920]
Diet therapy[MeSHID:D004035]
Hyperglycemia[MeSHID:D006943]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]
16.97 approved unknown
click here to return to the previous page